In addition, FAS is able to regulate epithelial-mesenchymal transition (EMT) of breast cancer cells via liver fatty acid-binding protein (L-FABP) and VEGF/VEGFR-2 mediated mechanism (Li et al., 2014a). The gene discussed is FAS; the disease is breast carcinoma.